Buy & Sell Southern Copper Corp (SCCO) – Southern Copper Corp Price Today
Aura AI Summary
Key Stats
- $147.49BMarket Cap
- Basic MaterialsSector
- -30.22%3M Drawdown
- $149.54BEnterprise Value
- 2.26%Dividend Yield
- 45 daysTypical Hold Time
Southern Copper Corp (SCCO) is currently valued at a market capitalization of $147.49B, with an enterprise value of $149.54B. Over the past 52 weeks, Southern Copper Corp has traded between a low of $90.42 and a high of $218.85, highlighting its annual price range. Over the past three months, Southern Copper Corp has recorded a drawdown of -30.22%, reflecting recent price volatility. Southern Copper Corp offers a dividend yield of 2.26%, with the most recent dividend of $1.00 paid on 13 May 26. On average, investors hold Southern Copper Corp for approximately 45 days, indicating typical investor behavior on the platform.
About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Most Recent News
Anthony Scaramucci says US trade deals helped China grow into a military superpower by acquiring US technology.
Anthony Scaramucci criticized the US decision to grant China permanent trade relations and WTO membership, saying it allowed China to protect its economy while exporting freely to the US. He argued that China used this advantage to take US technology...
CelLBxHealth partners with AdventHealth for US cancer trials using Parsortix CTC tech
CelLBxHealth has secured a collaboration with AdventHealth to use its Parsortix platform in two US clinical cancer studies, ACTION and SUNRISE. These trials will analyze circulating tumor cells (CTCs) from blood samples of patients with colon, gastro...
Netflix's ad tier hits 250M viewers; next challenge is proving value to command higher ad prices.
Netflix's ad-supported plan now reaches over 250 million global monthly active viewers, marking a major scale milestone. The company aims to convince advertisers that these viewers are valuable enough to pay premium prices, especially by leveraging l...